JANUX THERAPEUTICS INC shareholders Q3 2023

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

JANUX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 9,165,652$92,389,7721.82%
BVF INC/IL 4,579,818$46,164,5651.24%
Samsara BioCapital, LLC 360,414$3,632,9731.11%
Orbimed Advisors 3,317,927$33,444,7040.71%
Old Well Partners, LLC 10,300$103,8240.09%
Corton Capital Inc. 11,061$111,4950.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,150,000$11,592,0000.03%
XTX Topco Ltd 13,636$137,4510.02%
JANUS HENDERSON GROUP PLC 2,067,468$20,823,5930.01%
Alyeska Investment Group, L.P. 175,000$1,764,0000.01%
Woodline Partners LP 85,708$863,9370.01%
Citadel Advisors 3,431,209$34,586,5870.01%
FMR LLC 6,351,322$64,021,3260.01%
Trexquant Investment LP 11,773$118,6720.00%
EXCHANGE TRADED CONCEPTS, LLC 10,602$106,8680.00%
TWO SIGMA INVESTMENTS, LP 19,241$193,9490.00%
AMERICAN INTERNATIONAL GROUP, INC. 8,631$87,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,004$10,1200.00%
Ameritas Investment Partners, Inc. 1,706$17,1960.00%
DekaBank Deutsche Girozentrale 49,500$4840.00%
External links

This page lists JANUX THERAPEUTICS INC's shareholders in Q3 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.